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ABSTRACT
Hepatic involvement in extra-pulmonary 
tuberculosis (TB) is rare, even in the endemic 
area. It has a high mortality rate as it can easily 
be misdiagnosed due to its rarity and non-
specific presentations, and the treatment can be 
challenging for its hepatotoxic side-effect. A 55-
year old man who was newly diagnosed with AIDS 
and pulmonary TB which complicated with anti-
TB-induced transaminitis, presented with a few 
weeks history of fever and persistent diarrhoea. 
It was initially treated as microsporidia infection 
but the symptoms persisted despite given 
antiparasitic agent for more than a week. He was 
subjected to computed tomography (CT) scan 
of the abdomen and noted multiple hypoechoic 
lesion at multiple segments of the liver, which 
later confirmed to be liver TB by liver biopsy. As 
he could not tolerate Akurit-4 (Rifampicin 150 
mg, Isoniazid 75 mg, Pyrazinamide 400 mg and 
Ethambutol 275 mg), the second-line treatment 
was given instead. He is currently well on regular 
clinic appointment. The objective of this case 
report is to share the rare occurrence of hepatic 
TB and the difficulty to treat it as the hepatotoxic 
effect of anti-TB medications complicate the liver 
damage due to the infection.
INTRODUCTION 
Tuberculosis (TB) commonly affects the 
pulmonary system due to the nature of 
the organism that favours the high oxygen 
tension environment. Rarely, it also infects the 
liver which has lower oxygen concentration. 
This can occur with or without pulmonary 
involvement, and can either diffusely be 
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disseminated over the liver, or locally affect a 
single lobe1. Hepatic TB is relatively a curable 
disease. However, the delay in diagnosis and 
treatment can lead to fatal consequences2. 
Furthermore, the treatment has a side effect 
that causes liver injury which synergized the 
damage caused by the infection itself. This 
rare extra-pulmonary TB is the main focus of 
discussion in this case report.
CASE PRESENTATION
A 55-year old male who is newly diagnosed 
with AIDS presented with a history of fever and 
persistent diarrhoea for a few weeks. One month 
prior to the presentation, he was diagnosed 
with pulmonary tuberculosis (TB) started on 
3 tablets a day of oral Akurit-4 (Rifampicin 
150 mg, Isoniazid 75 mg, Pyrazinamide 400 
mg and Ethambutol 275 mg), which was 
appropriate to his body weight. However, he 
developed drug-induced hepatitis whereby 
his alanine aminotransferase went up to 
100 IU/L, therefore second-line medication 
was initiated which include intramuscular 
streptomycin, oral ethambutol and 
moxifloxacin. At that time, his CD4 counts 
were 15 cells/µL and the viral load of 127,000 
copies/mL. Currently, upon presentation, 
he was febrile and severely dehydrated 
requiring aggressive fluid resuscitation and 
inotropic support. He was empirically treated 
for microsporidia infection and was planned 
for 3-weeks of oral albendazole. He was also 
restarted on oral Akurit-4 as his liver function 
has normalized. However, he again developed 
marked transaminitis where his ALT jumped 
up four times from upper limit of normal 
after five days of restarting the medication 
which was then withheld and was changed 
back to second-line medications. Despite 
more than a week of oral albendazole, he 
still has persistent diarrhoea and intermittent 
fever. Blood cultures were negative. In view 
of persistent gastrointestinal symptoms with 
multiple spikes of temperature, CT scan of the 
abdomen was done and noted hypodense 
liver lesion in segment IV which suggestive of 
early liver abscess formation (Figure 1).
However, the delay in diagnosis and treatment can lead to fatal consequences2. Furthermore, the 
treatment has a side effect that causes liver injury which synergized the damage caused by the infection 
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Figure 1 CT scan of the liver showed the hypodense area in segment IV likely represent liver abscess 
Figure 1 CT scan of the liver showed the hypodense area in segment IV likely represent liver abscess
He was then empirically treated for 
pyogenic liver abscess. A serial abdominal 
ultrasound showed multiple new hypoechoic 
lesions on other segments of the liver (Figure 
2). As he was radiologically worsened, this 
raised the possibility of therapeutic failure. 
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 He was then empirically treated for pyogenic liver abscess. A serial abdominal ultrasound showed 
multiple new hypoechoic lesions on other segments of the liver (Figure 2). As he was radiologically 

















Figure 2 Ultrasound of the hepatobiliary system showed hypoechoic lesion over the segment II (left 
above), segment V (right above), segment VII (left bottom), segment VIII (right bottom) 
 
He has then proceeded with a liver biopsy and it showed chronic granulomatous inflammations (Figure 
3) with scattered acid-fast bacilli organism upon special stain with Ziehl-Neelsen (Figure 4) which 
suggestive of liver TB. The treatment with second-line anti-TB was continued, and oral isoniazid was 
added on day 42 of treatment in which he tolerated. He completed the treatment for a total of 1-year 
with 2-months of intensive phase which consist of all four medications, followed by ethambutol and 









Figure 2 Ultrasound of the hepatobiliary system showed hypoechoic lesion over the segment II (left 
above), segment V (right above), segment VII (left bottom), segment VIII (right bottom)
He has then proceeded with a liver 
biopsy and it showed chronic granulomatous 
inflammations (Figure 3) with scattered acid-
fast b cilli organism upon special stain with 
Ziehl-Neelsen (Figure 4) which suggestive of 
liver TB. The treatment with second-line anti-TB 
was continued, and oral isoniazid was added 
on day 42 of treatment in which he tolerated. 
He completed the treatment for a total of 
1-year with 2-months of intensive phase which 
consist of all four medications, followed by 
ethambutol and isoniazid for maintenance. 














Figure 3 Histopathological examination of the liver tissue biopsy showed scattered granulation tissue 












Figure 4 Microscopic examination under special staining showed scattered acid-fast bacilli organism 




Hepatic tuberculosis (TB) is rare which accounts only 1% of all TB infections1 and has a clinical 
presentation that highly mimics other common liver diseases such as pyogenic abscess, primary tumours 
and others. Classically it can present in three forms, and the commonest one is diffuse hepatic 
involvement seen along with pulmonary or miliary infection. This is seen in more than 50% of cases 
and is due to the haematogenous spread of mycobacteria via the hepatic artery. Patients are often 
asymptomatic despite the diffuse involvement of the liver. The second form is also known as 
Figure 3 Histopathological examination of the liver tissue biopsy showed scattered granulation tissue 
w th mixed nflammatory cells, predominantly histiocytes and occasional neutrophils.
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Figure 3 Histopathological examination of the liver tissue biopsy showed scattered granulation tissue 












Figure 4 Microscopic examination under special staining showed scattered acid-fast bacilli organism 




Hepatic tuberculosis (TB) is rare which accounts only 1% of all TB infections1 and has a clinical 
presentation that highly mimics other common liver diseases such as pyogenic abscess, primary tumours 
and others. Classically it can present in three forms, and the commonest one is diffuse hepatic 
involvement seen along with pulmonary or miliary infection. This is seen in more than 50% of cases 
and is due to the haematogenous spread of mycobacteria via the hepatic artery. Patients are often 
asymptomatic despite the diffuse involvement of the liver. The second form is also known as 
Figure 4 Microscopic examination under special staining showed scattered acid-fast bacilli organism 
which stained faint pink on Ziehl-Neelsen
DISCUSSION
Hepatic tuberculosis (TB) is rare which 
accounts only 1% of all TB infections1 and 
has a clinical presentation that highly 
mimics other common liver diseases such 
as pyogenic bscess, primary tum urs and 
others. Classically it can present in three forms, 
and the commonest one is diffuse hepatic 
involvement seen along with pulmonary or 
miliary infection. T is is seen in more than 50% 
of cases and is due to the haematogenous 
spread of mycobacteria via the hepatic artery. 
Patients are often asymptomatic despite 
the diffuse involvement of the liver. The 
second form is also known as granulomatous 
hepatitis, which is a diffuse hepatic infection 
without recognizable pulmonary involvement. 
The third and rarest form presents as a local 
tuberculoma1. Although hepatic TB relatively 
is a curable disease, it is associated with a 
high mortality rate. This is because hepatic 
TB lacks typical clinical presentations and 
diagnostic imaging features that make it 
easily misdiagnosed and causing delayed in 
treatment which lead to fatal consequences2. 
Acute liver failure secondary to TB infection 
was also reported but only in a few cases and 
most are associated with miliary TB3.
The common manifestations of hepatic 
TB are hepatomegaly, fever, abdominal 
pain and weight loss. Less commonly, it 
can also present with ascites, jaundice and 
splenomegaly. Patient with local hepatic 
TB may present with abdominal pain and 
jaundi e while mil ary hepatic TB may present 
with acute respiratory symptoms such as 
cough and sputum production4. Patient with 
elevated liver transaminases reflected the 
invol ement of liver parenchyma wher as 
elevated alkaline phosphatase and gamma-
glutamyl transferase suggestive of biliary 
tree involvement. However, our patient had 
hepatitis secondary to anti-TB and have cause 
a delay in the diagnosis of hepatic TB.
Radiological investigations such as 
ultrasound, computed tomography and 
magnetic resonance imaging are useful 
diagnostic tools. Liver tuberculoma appears 
as a non-enhancing low-density centre, owing 
to caseation necrosis with a slightly enhancing 
peripheral rim which corresponded to 
surrounding granulation tissue5. The contrast-
enhanced ultrasonography may be helpful 
in differentiating the diagnosis of hepatic TB 
from other hepatic focal lesions6. However, 
the most specific test is liver biopsy with 
mycobacterial culture. The demonstration 
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of acid-fast bacilli on special staining and 
caseous necrosis on biopsy can be very useful 
pathological tools but their absence cannot 
exclude the diagnosis. 
Apart from the diagnostic difficulty, 
another major challenge in managing hepatic 
TB is the risk of hepatotoxicity that can be 
induced by anti-TB drugs. The incidence of anti-
TB induced hepatoxicity is about 24.6%, with 
almost half occur within the first 2 weeks7. Chen 
HC et al. (2003) recommended treating the 
patient with hepatic TB with standard regimens 
despite the potential hepatotoxicity of these 
drugs, provided that the other cause of the 
liver injury must be excluded8. However, our 
patient developed transaminitis from the first 
line anti-TB after a few days of intensive phase, 
which have masked the liver injury caused by 
the infection. Therefore, he is not a suitable 
candidate for the first-line anti-TB treatment, 
especially oral pyrazinamide. But he did tolerate 
oral isoniazid and manage to take it for 1-year. 
CONCLUSION
In conclusion, this case report demonstrates 
the double-effect of the anti-TB drug in treating 
hepatic TB where in one hand it has good 
therapeutic value but in the other hand it also 
has a hepatotoxic side effect that synergizes 
the damage caused by the infection. This 
side effect can mask the liver involvement 
and results in diagnosis delay. Therefore, one 
needs to suspect liver infiltration for patients 
with disseminated TB who had deranged 
liver function secondary to anti-TB drugs and 
initiate the proper diagnostic investigations 
and effective treatment promptly in order to 
save lives.  
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